DEF 14A Filing

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

November 20, 2006

Period of Report

December 18, 2006

Accession Number

0001144204-06-048981

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →